Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition-Reference-Cited by-同舟云学术

Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition

Published:2022-02-25 Issue:4 Volume:102 Page:292-302
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry Part B Clinical

Author:

Das Nupur¹^ORCID,Dahiya Meetu¹,Gupta Ritu¹^ORCID,Rai Sandeep¹,Singh Saroj¹,Prajapati Vijay K.¹,Kumar Lalit²,Sharma Atul²,Sahoo Ranjit K.²,Gogia Ajay²

Affiliation:

1. Department of Laboratory Oncology Dr. B.R. Ambedkar IRCH, All India Institute of Medical Sciences (AIIMS) New Delhi India

2. Department of Medical Oncology Dr. B.R. Ambedkar IRCH, All India Institute of Medical Sciences (AIIMS) New Delhi India

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22062

Reference22 articles.

1. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

2. The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy;Bataille R.;Haematologica,2006

3. Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow

4. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates

5. DasN. DahiyaM. GuptaR. KumarL. SharmaA. RaiS. SinghS. PrajapatiV. K. SahooR. K.&GogiaA.(2021)Relevance of polyclonal plasma cells and post‐therapy immunomodulation in MRD assessment in multiple myeloma.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice;Clinical Lymphoma Myeloma and Leukemia;2023-11

2. Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry;Indian Journal of Medical and Paediatric Oncology;2023-04-24

3. Bohr–Rogosinski radius for a certain class of close-to-convex harmonic mappings;Canadian Mathematical Bulletin;2023-01-31

4. Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma —An evidence‐based approach;International Journal of Laboratory Hematology;2022-11-20

5. Graded Depth of Response and Neoplastic Plasma Cell Index as Indicators of Survival Outcomes in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant;American Journal of Clinical Pathology;2022-11-01